✦ LIBER ✦

Risk factors for recurrence of primary sclerosing cholangitis of liver allograft

✍ Scribed by Alonso Vera; Shazma Moledina; Bridget Gunson; Stefan Hubscher; Darius Mirza; Simon Olliff; James Neuberger

Book ID: 117282390
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 59 KB
Volume: 360
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)11861-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A re-evaluation of the risk factors for

A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts

✍ Edward Alabraba; Peter Nightingale; Bridget Gunson; Stefan Hubscher; Simon Ollif 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

Previously, we have found that the absence of the colon after liver transplantation (LT) protects the patient from recurrent primary sclerosing cholangitis (rPSC). As our previous observation has not been confirmed in other series, we have reviewed our cohort of patients grafted for primary sclerosi

Risk factors for recurrence of primary s

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

✍ Evangelos Cholongitas; Vibhakorn Shusang; George V. Papatheodoridis; Laura Marel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f

Risk factors for recurrence of primary s

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

✍ Jacob Alexander; James D. Lord; Matthew M. Yeh; Carlos Cuevas; Ramasamy Bakthava 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC

60 RISK FACTORS FOR RECURRENCE OF PRIMAR

60 RISK FACTORS FOR RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS

✍ E.B. Alabraba; P. Nightingale; B.K. Gunson; D.F. Mirza; J.M. Neuberger 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Fibrous and obliterative cholangitis in

Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis?

✍ Rebecca F. Harrison; Mervyn H. Davies; James M. Neuberger; Stefan G. Hubscher 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

Fibroobliterative lesions and fibrous cholangitis are characteristic histological lesions of primary sclerosing cholangitis. To determine whether such lesions can be found in the liver allograft, and whether they represent recurrent disease, we reviewed all consecutive histological material taken at

Recurrence of primary sclerosing cholang

Recurrence of primary sclerosing cholangitis following liver transplantation

✍ Ivo W. Graziadei; Russell H. Wiesner; Kenneth P. Batts; Paul J. Marotta; Nichola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views

Recurrence of primary sclerosing cholangitis (PSC) following liver transplantation has been suggested; however, it has not been fully defined because of numerous complicating factors and the lack of diagnostic criteria. In the present study, we investigated the recurrence of PSC by developing strict